Navigation Links
Clinical Evidence Grows in Support of CyberKnife Treatment for Intracranial and Extracranial Tumors
Date:2/26/2009

SUNNYVALE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced highlights from the clinical and technical presentations from its 8th Annual CyberKnife Users' Meeting, which was held February 4-7, 2009, in Hollywood, Fla. The record number of presentations featured during the event is a testament to the growing interest in use of the CyberKnife(R) Robotic Radiosurgery System for the non-invasive treatment of tumors anywhere in the body.

This year's CyberKnife Users' Meeting attracted more than 500 attendees, including surgeons, radiation oncologists, medical physicists, hospital administrators and other related clinical staff. More than 15 percent of those in attendance traveled from outside of the United States to participate. This year's scientific program grew noticeably from last year's with more than 85 oral presentations and 75 clinical and technical posters. The treatment of extracranial tumors was the focus of 47 of the oral presentations.

At this year's meeting, nine presentations reported on large-scale studies, each with more than 100 patients with brain, lung or prostate tumors. The 2009 Users' Meeting included 11 presentations related to prostate cancer treatment, with follow-up data approaching three years for many patients. In addition to updated outcomes with longer follow-up, researchers are extending CyberKnife applications for prostate cancer beyond early-stage disease. For example, clinicians discussed their use of CyberKnife radiosurgery to "boost" the radiation dose after conventional radiation therapy for patients with advanced disease, as well as for the treatment of recurrent cancer in patients that failed conventional radiation therapy.

The adoption of CyberKnife radiosurgery for th
'/>"/>

SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New Online, Media-Rich Educational and Clinical Resource in Anesthesiology Launched by McGraw-Hill Professional
2. CANTAM first African Network of Excellence for clinical trials
3. Stemedica Advances its Certification to Become a Licensed Manufacturer of Adult Stem Cells for U.S. Based Clinical Trials
4. Sopherion Therapeutics Announces Appointment of New Senior Executive Vice President for Clinical Affairs
5. Crescendo(tm), the Clinical and Translational Research Exchange, is Launched
6. DaVita Releases Top Clinical Priorities for 2009
7. Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From IMTECH for Clinical Development of the Small Molecule Caerulomycin and Its Proprietary Derivatives for Their Novel Indication of Immunosuppression
8. Musculoskeletal Clinical Regulatory Advisers, LLC Announces Signing of its 100th Client
9. Many Clinical Trials Moving Overseas
10. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
11. Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Volunteers from Scientology Churches and Missions are ... education lectures, forums and conferences, information stands, sports events, ... world. , Drug abuse is an international epidemic. According ... of alcohol and illicit drugs costs more than $425 ... and healthcare. , In the face of statistics ...
(Date:7/11/2014)... 11, 2014 The report, “Specialty ... Applications & Geography - 2018,” defines and segments ... with an analysis and forecast of the volumes ... fibers (Para aramids, meta aramids, UHMW Polyethylene, carbon ... PPS fiber, PBI fiber, PBO fiber, and liquid ...
(Date:7/11/2014)... 11, 2014 Utilizing the Keller Funnel, ... William Koenig, has topped a record number of complication-free ... performed over 400 successful procedures without the occurrence of ... well known across the country for his expertise with ... has long been the foundation for numerous studies and ...
(Date:7/11/2014)... 2014 (HealthDay News) -- Children who have emergency ... complications and potentially even death than those who ... However, the Johns Hopkins researchers noted that ... researchers analyzed data on nearly 440,000 simple emergency ... over a 22-year period. The surgeries are ...
(Date:7/11/2014)... The report “Probiotics Market by Products (Functional ... (Regular, Therapeutic, Preventive Health Care) & Ingredients (Lactobacilli, ... 2019 ” defines and segments the global probiotics ... market value of probiotic products and ingredients. The ... for the global market with an analysis of ...
Breaking Medicine News(10 mins):Health News:Scientologists Taking Action against Drug Abuse 2Health News:Scientologists Taking Action against Drug Abuse 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 2Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 4Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5
... experiences on anti-aging and ... personal beauty, ... public launch of the first consumer website dedicated,to consumer reviews and ... engage in an,open and honest conversation about important decisions that affect ...
... 11:00AM Adults with Attention Deficit Hyperactivity ... Extended-release Tablets showed significant improvements in ADHD symptom ... study results presented today at a major psychiatric ... adolescents with ADHD is clearly established but relatively ...
... Mid-Sized Companies Control Health Care Costs, DALLAS, ... Kenneth H. Cooper, M.D., M.P.H., Cooper Aerobics Enterprises,Inc., ... 37-year,history. Cooper Aerobics Enterprises purchased Health At Work, ... a new division, Cooper Benefits,LLC. Cooper Benefits ...
... have been found in related literature. One extremely rare ... of the World Journal of Gastroenterology because of its ... and sex factors, clinical and histopathological findings, diagnostic methods ... available literature. , The article reported one patient ...
... Ala. University of Alabama at Birmingham (UAB) researchers ... progression and switches on front-to-back body patterning in tadpoles. ... in understanding the complex DNA and cell interplay that ... and other diseases. , The UAB team focused on ...
... AMCS ),announces the following Webcast: (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ... 1, 2007 @ 8:30 AM ET, Where: http://www.videonewswire.com/event.asp?id=43463 ... on to the web at the address ... Inc, 617-779-7892. If you are unable to participate during the ...
Cached Medicine News:Health News:Consumers Open Up on RealSelf.com About 'Getting Work Done' 2Health News:Consumers Open Up on RealSelf.com About 'Getting Work Done' 3Health News:New study of Concerta showed significant improvement of ADHD symptom management in adults 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 2Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 3Health News:An Industry First: New Cooper Health Company Makes Group Employee Benefits Consulting and Wellness Program Design a Package Deal 4Health News:The largest colonic lipoma to date 2Health News:Cell pathway, disease linked to histone action 2
(Date:7/10/2014)... , July 10, 2014  The U.S. Department of ... grant to University Hospitals (UH) Case Medical Center Seidman ... national model aimed at improving care for patients with ... the project will test a unique model developed at ... late-stage disease, significant comorbidities, or demonstrated need for high ...
(Date:7/10/2014)... DIEGO , July 10, 2014  RESMED INC. (NYSE: ... its fourth quarter and fiscal year ended June 30, 2014 ... Stock Exchange market close. A press release with ResMed,s results ... the company will host a webcast to discuss operating results ... to begin at 1:30 p.m. US Pacific Time and the ...
(Date:7/10/2014)... LAVAL, Quebec , July 10, 2014  Valeant ... TSX: VRX) today announced it has completed the sale ... Sculptra, and Dysport owned or held by Valeant for ... agreement with Nestle S.A, which recently completed its acquisition ... complete the divestiture of our products to a company ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... 2, 2011 ViroPharma Incorporated (Nasdaq: VPHM ) ... officer of ViroPharma, will present at the Jefferies 2011 Global ... 2011.  The conference is being held in New York City. ... through www.viropharma.com and available for a period of ...
... be presented in a poster at the 2011 Annual Meeting ... in Chicago, Illinois June 3-7 by researchers from The University ... that a laboratory test developed by Biocept, Inc. for the ... Disseminated Tumor Cells (DTCs) can provide potentially valuable information to ...
Cached Medicine Technology:MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breast Cancer Patients 2MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breast Cancer Patients 3
... polymerase chain reaction (PCR) to amplify and ... first to fully automate and integrate all ... sample preparation, DNA amplification and detection. Designed ... PCR test results from a raw sample ...
... For use as a non-reactive quality assurance reagent ... Toxoplasma gondii (TOXO IgG and TOXO IgM), IgG ... and rubella IgM), IgG and IgM antibodies to ... IgM antibodies to herpes simplex virus types 1 ...
... a fully automated system with,a disposable ... new refractive procedure known,as Epi-Lasik. The ... epithelium from the,Bowmans membrane leaving a ... the structural integrity,of the stroma and ...
... is a surgical/ mechanical device designed to ... the cornea above Bowman's layer. The Centurion ... used during LASEK to delaminate the epithelium. ... providing a 'minimal-touch' surgical approach, the SES ...
Medicine Products: